Implicity
Implicity provides an AI-powered SaaS platform for remote cardiac monitoring of patients with cardiac implantable electronic devices, serving electrophysiologists, cardiologists, and device clinics across 250+ facilities in the US and Europe.
- Company typePrivate
- Founded2016
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Implicity does
Implicity is a Paris-based digital health company founded in 2016 by electrophysiologist Dr. Arnaud Rosier that provides an AI-powered SaaS platform for remote cardiac monitoring of patients with cardiac implantable electronic devices (CIEDs). The platform serves electrophysiologists, cardiologists, and cardiac device clinics, aggregating transmission data from all major CIED manufacturers — Abbott, Biotronik, Boston Scientific, Medtronic, and Microport — into a single vendor-agnostic interface. The platform is deployed across more than 250 medical facilities monitoring over 110,000 patients in the US and Europe.
The platform's core technology centers on proprietary AI algorithms that filter and interpret device transmissions. The FDA-cleared ILR ECG Analyzer is reported to reduce false positives by 79%, while SignalHF provides heart-failure risk prediction from CIED data and is also FDA 510(k)-cleared. AF Alert Management, CE-marked, is reported to reduce atrial-fibrillation alerts by 85%. Additional modules include InLink for EHR connectivity, Patient Connectivity Management, Dynamic Billing Engine, and Advanced Research Tool. The platform holds ISO 13485, ISO 27001, HDS, HIPAA, and GDPR certifications, and R&D is supported by an INSERM-affiliated team and a research partnership with France's Health Data Hub.
Implicity operates a hybrid business model combining SaaS subscriptions to its remote monitoring platform with IDTF (Independent Diagnostic Testing Facility) clinical services, and has a US presence through a Cambridge, Massachusetts headquarters. Revenue is generated through per-patient and per-facility subscriptions plus clinical-service fees, with additional non-dilutive grant funding (notably an EIC Accelerator award in July 2024) supplementing the $23M Series A closed in April 2022.
Implicity firmographics
Firmographics- Name
- Implicity
- Legal name
- Implicity
- Website
- https://implicity.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Implicity provides an AI-powered SaaS platform for remote cardiac monitoring of patients with cardiac implantable electronic devices, serving electrophysiologists, cardiologists, and device clinics across 250+ facilities in the US and Europe.
- Ownership category
- akta.pro rank
Implicity industry classification
Industry- Product category
- Remote Cardiac Monitoring Software
- NAICS
- Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cardiology Telemedicine Platforms (HLALAGAB)
- akta.pro secondary industries
- AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
Keywords
Where Implicity is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Implicity business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Software Platform Subscription (SaaS): Annual or multi-year subscription model for access to the Implicity remote cardiac monitoring platform with AI algorithms. Pricing is quote-based, customized to facility size and needs. Combines with optional IDTF clinical services for comprehensive solution.
- IDTF Clinical Services: Optional certified clinical review service provided through IDTF partner network, handling technical review of reports for compliance and billing CPT codes. Offers immediate scalability without requiring additional in-house staff.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription for healthcare facilities - custom pricing based on scale |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
Implicity product offering
Product offeringCore offering
Implicity provides a universal, cloud-based AI-powered remote cardiac monitoring platform that aggregates, normalizes, and standardizes data from all major cardiac implantable electronic device (CIED) manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, Microport) into a single dashboard. The platform is augmented by FDA-cleared Class II AI algorithms (e.g., ILR ECG Analyzer, SignalHF), CE-marked modules (AF Alert Management), automated patient reconnection, in-clinic data workflow tools, and a dynamic billing engine, complemented by optional IDTF clinical review services.
Product overview
Implicity offers a unified AI-powered remote cardiac monitoring platform that aggregates data from all major cardiac implantable electronic device manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, Microport) into a single interface. The core platform is complemented by specialized AI-powered modules including ILR ECG Analyzer (for false positive reduction in loop recorder analysis), SignalHF Predictive AI (for heart failure hospitalization prediction), AF Alert Management (for atrial fibrillation alert filtering), and Patient Connectivity Management (for automated patient reconnection). Additional tools include InLink (for in-clinic data workflow), Dynamic Billing Engine (for compliance and revenue optimization), and Advanced Research Tool (for clinical studies). The company also offers IDTF Clinical Services for outsourced technical review. All modules are designed to work together within the Implicity ecosystem to improve clinical outcomes, reduce alert fatigue, and optimize billing compliance.
Differentiator
Problem solved
Functional benefit
Products and services
- Implicity AI Cardiac Remote Monitoring Platform Universal, cloud-based AI-powered platform that aggregates, normalizes, and standardizes data from all cardiac implantable electronic device (CIED) manufacturers into a single dashboard for remote cardiac monitoring. Associated with 26% reduced mortality and 4% reduction in hospitalization length compared to conventional remote monitoring. Targets electrophysiologists, cardiologists, device clinic nurses, and technicians.
- ILR ECG Analyzer (IM007) FDA-cleared Class II AI algorithm (also CE-marked Class I) that reduces false positives by 79% when analyzing ECG recordings from Medtronic implantable loop recorders while maintaining 99% sensitivity. Detects asystole, bradycardia, atrial tachycardia/AF, ventricular tachycardia, normal rhythm, and artifacts. Designed for electrophysiologists and device clinics managing ILR patients.
- SignalHF Predictive AI FDA-cleared Class II AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing 90 days of physiological data, demographics, lead measurements, and episodes from CIEDs. First manufacturer-agnostic, pacemaker-compatible HF prediction algorithm; 75% of alerts are sent at least 14 days before hospitalization. Targets heart failure programs and electrophysiology/device clinics.
- AF Alert Management (IM009) CE-marked Class I medical device algorithm that analyzes device atrial burden data and clinical data (including anticoagulant medications) to filter irrelevant atrial fibrillation alerts and trigger smart alerts for significant AF care changes. Reduces unnecessary AF alerts by 85% versus standard CIED-transmitted alerts. For electrophysiologists, cardiologists, and device clinic staff.
- InLink Plug-and-play device for streamlining in-clinic data workflow. Securely transmits patient device data (PDF files and raw data from all manufacturers) from programmers during in-clinic visits directly to the Implicity platform, eliminating manual USB transfers. For device clinic staff and nurses.
- Patient Connectivity Management Automated reconnection tool that sends SMS messages to patients who disconnect from remote monitoring. Reconnects 28% of patients within two days after disconnection, with automated pause/resume of alerts based on reconnection status. For device clinic operations teams.
- Dynamic Billing Engine Automated billing and compliance engine integrated into the clinical monitoring platform. Tracks completed remote monitoring transmissions, generates compliant reports, and optimizes scheduling to achieve 90%+ billing compliance. For healthcare admin and billing teams.
- Heart Failure Remote Monitoring Module for heart failure patients with CIEDs that aggregates thoracic impedance, arrhythmia burden, patient activity, and nighttime heart rate data, integrating with SignalHF for predictive hospitalization risk assessment. For cardiology and heart failure programs.
- IDTF Clinical Services Certified Independent Diagnostic Testing Facility clinical review service that handles technical review of reports generated by Implicity's AI, ensuring compliance and technical accuracy for billing optimization. Enables the 'All-in-One' offering combining AI technology with certified clinical services. For healthcare providers needing outsourced clinical review and CPT billing support.
- Advanced Research Tool Research data platform providing raw data access, normalized patient data across manufacturers, centralized multi-hospital network data, customized eCRF, and patient consent tracking for clinical studies. For clinical researchers, academic medical centers, and consortium studies such as DAI-PP.
Quantifiable outcome
- 26% reduction in all-cause mortality compared to conventional remote monitoring (HR 0.74; 95% CI 0.73-0.77)
- +9 more outcomes
Companies that use Implicity
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles2 records
Implicity technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability7 records
Feature6 records
Implicity partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and key.
- DAI-PP ConsortiumcoreImplicity is the official remote monitoring platform of one of the largest European research programs on ICDs - a consortium of 17 universities and private hospitals in France conducting massive real-time follow-up of ICD patients since January 2020. Expected to enroll 5,000+ patients. Supported by French Society of Cardiology, INSERM, and Clinique Pasteur.
- Cordeliers Research Centre (CRC) - INSERM UMR 1138coreTeam 22 of INSERM UMR 1138 supports Implicity's R&D team in developing AI algorithms through expertise-sharing in biomedical informatics and applied mathematics to exploit full potential of AI for healthcare research.
- Health Data Hub (France)coreImplicity is the only private company authorized to access the Health Data Hub - one of the world's largest databases of heart disease patients encompassing nearly the entire French cardiac patient population. Enables more robust AI training and validation. Hydro project was first project approved by French Data Protection Agency (CNIL) in May 2020.
- IDTF Partners (Independent Diagnostic Testing Facilities)keyNetwork of certified IDTF partners providing clinical review services alongside Implicity's software platform, enabling the 'All-in-One' offering that combines AI technology with certified clinical services. Partners handle technical review for compliance and CPT billing.
- Abbott, Biotronik, Boston Scientific, Medtronic, MicroportcoreImplicity integrates with cardiac implantable electronic devices from all major manufacturers, aggregating and normalizing data from Abbott, Biotronik, Boston Scientific, Medtronic, and Microport into a single unified dashboard. SignalHF algorithm is compatible with Biotronik, Boston Scientific, and Medtronic CIEDs.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Implicity competitors and assessment
Company assessmentDirect peers
- Vector Remote Care: Direct competitor offering remote cardiac monitoring services for CIED patients with manufacturer-agnostic data aggregation. Competes head-to-head with Implicity in US device clinics for similar electrophysiology and cardiology customers.
Broad incumbents
- Medtronic: Major CIED manufacturer with its own CareLink remote monitoring network. While not a direct software competitor, Medtronic's bundled device-plus-monitoring offering competes for the same budget and customer relationships Implicity targets.
- Boston Scientific: CIED manufacturer with LATITUDE remote monitoring platform serving its installed base. Represents both an integration partner and a competitive threat as manufacturers strengthen their own remote monitoring offerings.
- Abbott: CIED manufacturer operating Merlin.net remote monitoring for its cardiac device portfolio. Implicity aggregates data from Abbott devices while Abbott's native platform competes for the same device clinic relationships.
- Royal Philips (BioTelemetry): Acquired BioTelemetry to offer cardiac monitoring services at scale. Philips provides both ambulatory ECG monitoring (eCardio) and CIED monitoring services, competing for the same hospital and IDTF budgets as Implicity.
- Biotronik: CIED manufacturer with Home Monitoring platform. Biotronik is both a device integration partner (Implicity's SignalHF works with Biotronik devices) and a competitor via its own remote monitoring offering.
Emerging players
- iRhythm Technologies: AI-driven cardiac monitoring company (Zio long-term continuous monitor). Focuses on ambulatory ECG rather than CIED remote monitoring, but competes for cardiology budget and represents the broader shift to AI-enabled cardiac diagnostics.
- HeartBeam: Early-stage cardiac diagnostics company developing AI-enabled ECG technology. Different modality (synthesized 12-lead ECG) but comparable in applying AI to cardiac arrhythmia detection and cardiac monitoring.
- Eko Health: AI-powered cardiac auscultation and ECG platform with FDA-cleared algorithms. Competes in the broader cardiac AI diagnostics category with a different clinical entry point (digital stethoscope + handheld ECG).
- AliveCor: AI ECG company with FDA-cleared KardiaMobile devices and platform. Serves a more consumer and ambulatory cardiology segment, but competes in the broader cardiac AI monitoring market with similar FDA regulatory pathway and clinical positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Implicity social profiles
Digital presenceImplicity compliance and trust
Trust signalCompliance8 records
Implicity financial estimates
Financial estimateRevenue estimate
Valuation estimate
Implicity leadership team
Management profileNumber of profiles
Profiles7 records
Implicity funding detail
Funding detailFunding overview
Funding rounds6 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Implicity M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Implicity
What does Implicity do?
Implicity provides a universal, cloud-based AI-powered remote cardiac monitoring platform that aggregates, normalizes, and standardizes data from all major cardiac implantable electronic device (CIED) manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, Microport) into a single dashboard. The platform is augmented by FDA-cleared Class II AI algorithms (e.g., ILR ECG Analyzer, SignalHF), CE-marked modules (AF Alert Management), automated patient reconnection, in-clinic data workflow tools, and a dynamic billing engine, complemented by optional IDTF clinical review services.
Is Implicity a public or private company?
Implicity is a private company. It is classified as venture growth investor backed and is currently operating.
When was Implicity founded?
Implicity was founded in 2016. It employs 11 to 50 people.
Where is Implicity based?
Implicity is headquartered in Paris, France, in the Europe region.
How does Implicity make money?
Two revenue lines are on record. Software Platform Subscription (SaaS) is the primary driver. The others are IDTF Clinical Services.
Who are Implicity's main competitors?
Vector Remote Care is listed as a direct peer. Broad incumbents are Medtronic, Boston Scientific, Abbott, Royal Philips (BioTelemetry) and Biotronik. Emerging players are iRhythm Technologies, HeartBeam, Eko Health and AliveCor.
Does Implicity have an API?
No public API is recorded for Implicity.
What industry is Implicity in?
Implicity's product category is Remote Cardiac Monitoring Software. Its primary akta.pro industry code is HLALAGAB, Cardiology Telemedicine Platforms, with a secondary code of HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive). Its NAICS code is 541511 and its SIC code is 3841.